COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff. Learn more about attendance requirements for live courses and conferences and available COVID-19 online education and resources.

Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2022

Las Vegas, NV US
October 21, 2022 to October 22, 2022

This course offers Live (in-person) and Livestream (virtual) attendance options

Course Directors: Tanios S. Bekaii-Saab, M.D., Mitesh J. Borad, M.D., Sean P. Cleary, M.D., and G. Dan Duda, D.M.D., Ph.D.

October 21 - 22, 2022 - Wynn Las Vegas, Las Vegas, Nevada

In collaboration with the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO)

Nationally and internationally renowned faculty provide a state-of-the-art update on the latest treatment options for patients with hepato-pancreatico-biliary cancers. The symposium is designed to provide a multidisciplinary overview on the importance of early diagnosis and treatment considerations, including surgery, radiation, loco-regional approaches, and systemic therapies. The symposium emphasizes implementation of these approaches into clinical practice.

LIVE (in-person) attendees must comply with all live course requirements and guidelines and applicable state and local COVID-19 travel restrictions, guidance and resources.  

Please note that LIVE course attendees must: 

  • Complete COVID-19  testing of any kind (home tests are acceptable) and received a negative test result within 72 hours of the event start date OR
  • A positive COVID-19 test result of any kind was received within the past 90 days, it has been at least 10 days since COVID-19 infection, and you are currently asymptomatic.  
  • You must be logged in to ce.mayo.edu to  complete your attestation.   (Attestations can be completed starting Tuesday, October 18, 2022) 

Learners who do not fulfill the above requirements will be unable to attend this live (in-person) event. 

Requirements and guidelines may be amended as CDC, public health and other relevant guidance are adjusted.

 

Target Audience

This course is intended for surgeons, gastroenterologists, medical and radiation oncologists, laboratory scientists, physician assistants, nurse practitioners, registered nurses, oncology pharmacists, oncology nurses and clinical research personnel. Specialties include: medical oncology, hematology, gastroenterology, radiation oncology, surgical oncology, pathology, radiology, and laboratory research science.

Learning Objectives

Upon conclusion of this program, participants should be able to:

  • Describe innovative options for patients with pancreas, liver and biliary cancers with limited oligometastatic disease.
  • Identify current and emerging strategies for early diagnosis and surveillance of liver cancer.
  • Identify patients suitable for a liver transplantation, surgical resection, radiation therapy, or other loco-regional approaches.
  • Integrate novel molecularly-targeted, as well as immune-based, therapeutic strategies in clinical care and clinical trial participation.
  • Recognize the appropriate regimen for first and second line therapy in treating advanced pancreatic cancer, liver and biliary cancer.
  • Describe the latest state of the science in pancreatic cancer, liver and biliary cancer.

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Course summary
Available credit: 
  • 9.25 ABIM
  • 9.25 AMA PRA Category 1 Credit
  • 9.25 Attendance
Event starts: 
10/21/2022 - 8:00am
Event ends: 
10/22/2022 - 12:45pm

Click here to view Program Schedule on mobile

 
Wynn Las Vegas
3131 South Las Vegas Boulevard
Las Vegas, NV 89109
United States
+1 (702) 770-7000

 

 

 

 

 

 

 


We apologize, but due to high interest in the HPB course, the group room block is sold out.      

Mayo Clinic is closely monitoring COVID-19 prevalence and may adjust live course attendance limits as necessitated by CDC, public health and other relevant guidelines. Attendees are asked to comply with all live course and conference guidelines.

All travel and lodging expenses are the sole responsibility of the individual registrant.

Course Directors

Tanios S. Bekaii-Saab, M.D.
Professor of Medicine, Mayo Clinic College of Medicine and Science
Mayo Clinic
Phoenix, Arizona

Mitesh J. Borad, M.D.
Professor of Medicine, Mayo Clinic College of Medicine and Science
Mayo Clinic
Phoenix, Arizona

Sean P. Cleary, M.D.
Professor of Surgery, Mayo Clinic College of Medicine and Science
Division Chair, Hepatobiliary/Pancreatic Surgery
Mayo Clinic
Rochester, Minnesota

G. Dan Duda, DMD, PhD, FAIMBE, FAAAS
Director of Translational Research in GI Radiation Oncology,
Massachusetts General Hospital
Investigator, Edwin L. Steele Laboratories for Tumor Biology,
Massachusetts General Hospital Research Institute
Associate Professor of Tumor Biology, Harvard Medical School 
Massachusetts General Hospital
Boston, Massachusetts

Guest Faculty

Mehmet Akce, M.D.
The Kirklin Clinic of UAB Hospital
Birmingham, Alabama

Anthony B. El-Khoueiry, M.D.
Associate Director, Clinical Research
University of Southern California
Norris Comprehensive Cancer Center
Los Angeles, California

Bassel El-Rayes, M.D.
Deputy Director
O’Neal Cancer Center, University of Alabama
Birmingham, Alabama

Richard S. Finn, M.D.
Professor of Medicine
Geffen School of Medicine
UCLA Division of Hematology/Oncology
Santa Monica, California

James J. Harding, M.D.
Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, New York

Milind Javle, M.D.
Assistant Professor, Roswell Park Cancer Institute, Buffalo
MD Anderson Cancer Center
Houston, Texas

Subam Pant, M.D.
Associate Professor, Department of Gastrointestinal Medical Oncology
MD Anderson Cancer Center
Houston, Texas

Michael Jon Pishvaian, M.D., Ph.D.
Director of Gastrointestinal, Developmental therapeutics and
Clinical Research Programs
Associate Professor of Oncology
Johns Hopkins Medicine
Washington, D.C.

Sanford M. Simon, Ph.D.
Rockefeller University
New York, New York

Matthew John Weiss, M.D.
Professor of Surgery
Deputy Physician-in-Chief, Director of Surgical Oncology
Northwell Health Cancer Institute
New Hyde Park, New York

Mayo Clinic Faculty

Daniel H. Ahn, D.O.
Associate Professor of Medicine

Bashar A. Aqel, M.D.
Associate Professor of Medicine

Christopher (Chris) L. Hallemeier, M.D.
Associate Professor of Radiation Oncology

Lionel A. Kankeu Fonkoua, M.D.
Instructor in Medicine

Nitin N. Katariya, M.D.
Assistant Professor of Surgery

Wen Wee Ma, M.B.B.S.
Professor of Oncology

Douglas L. Riegert-Johnson, M.D.
Assistant Professor of Medicine
Assistant Professor of Medical Genetics

Kumar Sandrasegaran, M.B.Ch.B.
Professor of Radiology

Terence T. Sio, M.D., M.S.
Associate Professor of Radiation Oncology

Mohamad (Bassam) B. Sonbol, M.D.
Assistant Professor of Medicine

Timucin Taner, M.D., Ph.D.
Professor of Surgery

Cornelius A. Thiels, D.O., M.B.A.
Assistant Professor of Health Services Research
Assistant Professor of Surgery

Beau Toskich, M.D.
Associate Professor of Radiology

Mark J. Truty, M.D., M.S.
Associate Professor of Surgery

 

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):

AMA
Mayo Clinic College of Medicine and Science designates this Other activity (Live and Livestream) for a maximum of 9.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

DayCredit
Friday5.25
Saturday4.00

ABIM
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Available Credit

  • 9.25 ABIM
  • 9.25 AMA PRA Category 1 Credit
  • 9.25 Attendance

For information regarding exhibit opportunities, please reach out to Kristy Badder.

 
Status
Price
Title
$515.00Included
Please login or register to take this course.
$515.00Included
Please login or register to take this course.
Please login or register to take this course.

LIVE (in-person) attendees must comply with all live course requirements and guidelines and applicable state and local COVID-19 travel restrictions, guidance and resources.  

Please note that LIVE course attendees must: 

  • Complete COVID-19  testing of any kind (home tests are acceptable) and received a negative test result within 72 hours of the event start date OR
  • A positive COVID-19 test result of any kind was received within the past 90 days, it has been at least 10 days since COVID-19 infection, and you are currently asymptomatic.  
  • You must be logged in to ce.mayo.edu to  complete your attestation.   (Attestations can be completed starting Tuesday, October 18, 2022) 

Learners who do not fulfill the above requirements will be unable to attend this live (in-person) event. 

Requirements and guidelines may be amended as CDC, public health and other relevant guidance are adjusted.
 


Cancellation and Refund Policy

View Cancellation and Refund Policy

All requests must be submitted in writing using the Contact Us Form.

Any use of this site constitutes your agreement to the Terms and Conditions of Registration.